glp 1 ketoacidosis New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review GLP-1 Medications – Community Education

Safety considerations for GLP-1RA use Based on current data from clinical trials in MASLD and longer-term cohorts in T2DM and obesity, GLP-1RA is generally considered safe

All procedures were performed in accordance with relevant guidelines and regulations

September 20 Product: Zevra Therapeutics Miplyffa Indication: Niemann-Pick disease type C Patients with Niemann-Pick disease type C (NPC) have their first treatment after the FDA approved Zevra Therapeutics Miplyffa for the ultra-rare, progressive neurodegenerative disease

KPV is a premium grade (99%+ purity) research peptide in lyophilized solid (freeze dried) form